|Day Low/High||11.50 / 11.88|
|52 Wk Low/High||4.81 / 13.33|
There is still a very strong appetite for individual stocks with momentum.
If you're looking for something negative to say about this action about the only thing you might argue is that the action is too positive.
I'm trying not to be sucked into the market-timing game and am looking mainly at setups in individual stocks.
But you need to be selective and have discipline.
We have shifted from a market that was mainly index driven by the FAANG names to one where stock picking is more important.
The Boston firm said microbiology data show that investigational antibiotic omadacycline is 'active against the clinically important typical and atypical community-acquired bacterial pneumonia (CABP) pathogens.'
I've cut a few positions and haven't made any notable buys today.
There are few standout stocks, but there is broad strength so far today.
Here's what I'm trading today amid the 'flat with a positive tone' action.
Adam Feuerstein, Sr. Columnist for TheStreet, says Ligand, BioMarin and Sangamo are the next big things to watch in biotech.